Patrick G Enright
Director at Veradermics, Inc (MANE); Director at Vera Therapeutics, Inc. (VERA); Director at Zenas BioPharma, Inc. (ZBIO)
Purchase track record
Strong record. Based on 3 purchases with a full 90 days of price history.
98
Avg. 90-day return+51.1%
vs. S&P 500+47.0%
Beat the market33%
Paper profit on buys+$123M
Total bought / sold$20.8M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 5SEC | MANEVeradermics, Inc | Buy | 192,6472,600,399 held (+8%) | $17.00 | $3.3M | +670.0% |
| Feb 5SEC | MANEVeradermics, Inc | Buy | 882,3532,053,474 held (+75%) | $17.00 | $15.0M | +670.0% |
| Dec 15SEC | VERAVera Therapeutics, Inc. | Buy | 5,882new position | $42.50 | $250K | -29.7% |
| Oct 14SEC | ZBIOZenas BioPharma, Inc. | Buy | 105,2651,832,669 held (+6%) | $19.00 | $2.0M | +43.5% |
| Oct 14SEC | ZBIOZenas BioPharma, Inc. | Buy | 11,990new position | $20.85 | $250K | +30.7% |
- Buy
Director Patrick G Enright bought $3.3M of MANE at $17.00 — first open-market purchase in our records.
- Buy
Director Patrick G Enright bought $15.0M of MANE at $17.00 — largest purchase by this insider in our records; raises the stake by 75%.
- Buy
Director Patrick G Enright bought $250K of VERA at $42.50 — first open-market purchase in our records; opens a new position.
- Buy
Director Patrick G Enright bought $2.0M of ZBIO at $19.00 — first open-market purchase in our records.
- Buy
Director Patrick G Enright bought $250K of ZBIO at $20.85 — opens a new position.